Indaptus Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.1% | +20.2% | -7.3% | +63.0% | +8.5% | -3.0% | +27.5% | -6.0% | +18.3% | +3.6% | -0.6% | -99.9% | +64.7% | +26.9% | -27.9% | -42.8% | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | +12.5% | +979.1% | +95.8% | +0.3% | -22.3% | -41.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | +12.5% | +979.1% | +86.9% | – | – | – | |
| – | +6.1% | -569.3% | – | -202.0% | – | -107.3% | – | – | +1,198.5% | -112.6% | – | -47.7% | -4,388.4% | – | – | – | +795.9% | |
| – | +160.2% | -10.2% | +386.5% | -91.1% | +621.6% | -94.9% | +1,736.3% | -65.4% | +937.6% | +91.9% | -90.4% | +791.2% | -100.0% | +4,377.3% | -100.0% | -100.0% | – | |
| – | +180.2% | +888.9% | – | -230.9% | +103.6% | – | -335.4% | – | -200.5% | +95.9% | -65.5% | – | +0.0% | -3,768.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +365.3% | – | – | – | – | – | |
| – | +15.9% | +175.9% | -76.3% | +13.4% | +174.9% | -48.0% | +561.5% | – | – | -45.0% | -93.2% | -50.9% | +4,055.7% | -99.2% | -100.0% | – | +269.5% | |
| – | – | – | – | – | – | – | – | -141.3% | – | -138.3% | – | – | – | -178.7% | – | -302.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.